Search

everythinglearnresearchcommunity

for

Search:↓

Changes in the SREBF1 gene cause a rare genetic skin and hair disorder.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Vertex pattern hair loss linked to higher prostate cancer risk.

Minoxidil-loaded liposomes effectively deliver to hair follicles, potentially improving hair growth and treating alopecia.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Mutations in the p63 gene affect skin adhesion, barrier integrity, and hair growth.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

5-alpha reductase inhibitors are generally safe but can cause sexual side effects and require patient education on risks.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

The document concludes that recognizing oral lesions is important for diagnosing syphilis.

People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

The conclusion is that understanding how hair follicle stem cells live or die is important for maintaining healthy tissue and repairing injuries, and could help treat hair loss, but there are still challenges to overcome.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Silver nanoparticles made from Grewia optiva leaf extract show strong antibacterial, antioxidant, and hair growth benefits.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

Skin problems can be linked to sexual abuse, requiring careful medical and psychological evaluation.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Late pregnancy helps repair brain damage in rats due to the GABAergic system.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

Women with high androgen levels may have more severe COVID-19 symptoms.

The document concludes that managing PCOS effectively requires considering ethnic differences, obesity's impact, and ethical concerns in treatment approaches.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.